Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 24 of 25
NIRS Monitoring in the Ambulatory Single Ventricle Patient
NCT00166218
Quality of Life in Patients Post Radiofrequency Ablation
NCT00165997
Safety and Effectiveness of Computer Screening for Intimate Partner Violence
NCT00166062
Mental Health Symptoms and Intimate Partner Violence
NCT00166075
Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy
NCT00165984
Critical Congenital Heart Defect (CHD) Outcomes in Children
NCT00208689
Recovery From General Anesthesia
NCT00165971
Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI
NCT00166179
Muscle Relaxation Therapy With Odorant Cue
NCT00208910
Effect of Cola on Urinary Stone Risk Factors
NCT00289120
Terminal Graft Failure
NCT00208884
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
NCT00208819
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
NCT00231309
Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
NCT00209014
Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
NCT00209001
Cardiopulmonary Circuits in the Pediatric Population
NCT00208728
Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT00124202
A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening
NCT00208988
Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors
NCT00966498
Effects of Hemodialysis on the Sleep/Wake Cycle
NCT00460863
The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - "The Sleep Cool Study"
NCT00218790
Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.
NCT00208715
Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)
NCT00590005
Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
NCT00379418
Mental Imagery to Reduce Motor Deficits in Stroke
NCT00379392
Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept
NCT00166153
Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.
NCT00166140
S.T.A.R.S.: Sistas Talking About Real Solutions
NCT01028157
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
NCT00208949
NIRS in Neonatal Cardiac Surgery
NCT00166101
Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
NCT00133809
Endothelial Hyperpolarization in Humans
NCT00166166
Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab
NCT00208975
Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
NCT00208741
HORIZONS HIV Intervention
NCT00633906
Depression, Epinephrine, and Platelet Function
NCT00166114
Sensorimotor Gating in Schizophrenia
NCT00561561
Psychoeducational Intervention for ICD Patients (PEACE)
NCT00146679
Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder
NCT00209040
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
NCT00021866
Recovery of Visual Acuity in People With Vestibular Deficits
NCT00411216
Adult Congenital Heart Disease Surgery
NCT00446160
Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive Therapy
NCT00209066
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
NCT00208962
Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
NCT00003551
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
NCT00208923
ADPKD Cohort Study
NCT02084849
Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?
NCT00208897
Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function
NCT00313352
Diet/Growth Factor Mechanisms of Gut Adaptation
NCT00067860
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.